◆ €500m 4NC3 EuGB deal priced inside fair value ◆ Greenium helps tighten spreads amid strong demand ◆ Landmark trade cements bank's ESG leadership, says treasurer

◆ Austrian lender completes its tightest unsecured debt since the start of war in Ukraine… ◆ …as BPM achieves its lowest ever senior spread ◆ High attrition function of premium and outright spread

◆ Issuer finds window between political volatility and supply onslaught ◆ Deal sets record low spread for callable sterling senior bail-in debt ◆ Investors remain on board despite tight price

◆ Deal unaffected by Japanese macro volatility, lead said ◆ Aggressive pricing led to heavy long-end attrition ◆ Continuing trend of heavy supply for dual tranche holdco senior trades

◆ Belgian utility goes for 10 year paper ◆ Issuer set final size at guidance ◆ Deal skims through fair value

◆ First IG corporate SLB of the year ◆ Deal lands at tight end of guidance ◆ Interest in SLB format on the slide

Only one of Canada's big five banks has yet to publicly support new defence bank initiative

Hyperscaler earnings could become a crucial date for issuance funding calendars

Cologix taps private ABS for latest trade

Chemical sector's growing uncompetitiveness a problem when it comes to attracting investment in the capital markets

Canada throwing full weight behind plan for new multilateral lender for defence funding

Second Canadian lender to declare official support for embryonic SSA issuer as government takes lead on establishing new entity

◆ Second ever bond for the issuer ◆ Deal marketed to both SSA and credit investors ◆ Offers potential for tightening on the back of southern European convergence trade

BSTDB has had a tricky time since Russia attacked Ukraine, both of which are shareholders

Commodities trader halves its stake for £132m after shares soar

◆ Deal follows NextEra’s euro hybrid debut last year ◆ Eight year tranche draws the larger book ◆ More Reverse Yankee issuance expected to follow

The familiar problem of inter-creditor opacity has also reappeared

'Hard to classify' Italian corporate trade being marketed to FIG and SSA accounts

Craig Coben examines whether it is true that no good deed goes unpunished

Investors and bankers grapple with 24% fall in Bitcoin since deal was rated

Investment banking travel was a relentless grind, not gold card access to global glamour

Commercial real estate has been one of the hardest hit sectors during the Covid-19 pandemic. The images of shuttered shops and empty offices are almost as emblematic of the Covid crisis as facemasks and stay-at-home warnings. Although there is hope for a recovery in issuance led by the red-hot growth in logistics sites, the outlook is uncertain given that underlying values of many properties backing existing CMBS remain unknown. Sam Kerr reports.

In mid-May GlobalCapital convened representatives of three RMBS issuers with different business models and approaches for a wide-ranging discussion about the state of the UK mortgage markets, funding strategies, and much more. Kensington is the most frequent issuer in European RMBS, with a track record stretching back to 1995, and more than £10bn of assets under management, including about £6bn of servicing mandates. LendInvest and Habito are fintech lenders, with LendInvest originating bridging loans and buy-to-let, funded through securitizations (LendInvest has completed two public deals so far), retail bonds, funds, and private capital, including a £500m partnership with JP Morgan. Habito mixes technology-enabled mortgage broking with its own buy-to-let originations, funded through Citi’s securitization shelf, and has recently launched the first long-term (up to 40 years) fixed rate mortgage product in the UK, funded through a partnership with CarVal Investors.

AstraZeneca, the UK drug company, showed the eager demand for merger and acquisition financings this week when it achieved ultra-tight pricing on a $7bn bond issue to fund its acquisition of US biotech firm Alexion Pharmaceuticals.